Gardie Acquisition of data (provided animals, acquired and managed patients, provided facilities, etc Gardie Analysis and interpretation of data (e.g., statistical analysis, biostatistics, computational analysis, Mole, W. Kaelin, B. Gardie Writing, review, and/or revision of the manuscript: S. Couv e ,
Gardie Administrative, technical, or material support (i.e., reporting or organizing data, constructing databases, Gardie Other (performed laboratory techniques such as Western blot analysis, PCR, etc.): H. Le Jeune Other (provision of animals, acquisition and management of patients, provision of facilities, etc.): M. Le Gentil References ,
A continuum model for tumour suppression, Nature, vol.129, issue.7359, pp.163-172, 2011. ,
DOI : 10.1038/nature10275
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3206311
The tumour suppressor protein VHL targets hypoxiainducible factors for oxygen-dependent proteolysis, Nature, vol.399, pp.271-276, 1999. ,
Structure of the VHL-ElonginC-ElonginB Complex: Implications for VHL Tumor Suppressor Function, Science, vol.284, issue.5413, pp.455-61, 1999. ,
DOI : 10.1126/science.284.5413.455
Phenotypic expression in von Hippel-Lindau disease: correlations with germline VHL gene mutations., Journal of Medical Genetics, vol.33, issue.4, pp.328-360, 1996. ,
DOI : 10.1136/jmg.33.4.328
Genetic analysis of von Hippel-Lindau disease, Hum Mutat, vol.31, pp.521-558, 2010. ,
Hypoxia-Inducible Factor Linked to Differential Kidney Cancer Risk Seen with Type 2A and Type 2B VHL Mutations, Molecular and Cellular Biology, vol.27, issue.15, pp.5381-92, 2007. ,
DOI : 10.1128/MCB.00282-07
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1952077
Ubiquitination of hypoxia-inducible factor requires direct binding to the beta-domain of the von Hippel-Lindau protein, Nat Cell Biol, vol.2, pp.423-430, 2000. ,
Solid renal tumor severity in von Hippel Lindau disease is related to germline deletion length and location, Human Mutation, vol.91, issue.1, pp.40-46, 2004. ,
DOI : 10.1002/humu.10302
Disruption of oxygen homeostasis underlies congenital Chuvash polycythemia, Nature Genetics, vol.59, issue.4, pp.614-635, 2002. ,
DOI : 10.1016/0167-4889(90)90126-X
In vitro and In vivo Models Analyzing von Hippel-Lindau Disease-Specific Mutations, Cancer Research, vol.64, issue.23, pp.8595-603, 2004. ,
DOI : 10.1158/0008-5472.CAN-04-1430
Congenital disorder of oxygen sensing: association of the homozygous Chuvash polycythemia VHL mutation with thrombosis and vascular abnormalities but not tumors, Blood, vol.103, issue.10, pp.3924-3956, 2004. ,
DOI : 10.1182/blood-2003-07-2535
Genetic Basis of Congenital Erythrocytosis: Mutation Update and Online Databases, Human Mutation, vol.367, issue.1, pp.15-26, 2014. ,
DOI : 10.1002/humu.22448
von Hippel-Lindau mutation in mice recapitulates Chuvash polycythemia via hypoxia-inducible factor-2alpha signaling and splenic erythropoiesis, J Clin Invest, vol.117, pp.3879-89, 2007. ,
RUNX1 and NF-E2 upregulation is not specific for MPNs, but is seen in polycythemic disorders with augmented HIF signaling, Blood, vol.123, issue.3, pp.391-395, 2014. ,
DOI : 10.1182/blood-2013-10-534222
Dysregulation of the HIF pathway due to VHL mutation causing severe erythrocytosis and pulmonary arterial hypertension, Blood, vol.117, issue.13, pp.3699-701, 2011. ,
DOI : 10.1182/blood-2010-12-327569
Cancer Research OF10 16 The homozygous VHL missense mutation is associated with dramatically elevated erythropoietin levels, consequent polycythemia, and early onset severe pulmonary hypertension, Cancer Res Pediatr Blood Cancer, vol.7461, issue.22, pp.2104-2110, 2014. ,
DOI : 10.1002/pbc.25056
Mutations in the von Hippel-Lindau (VHL) tumor suppressor gene and VHL-haplotype analysis in patients with presumable congenital erythrocytosis, Haematologica, vol.90, pp.19-24, 2005. ,
The worldwide distribution of the VHL 598C>T mutation indicates a single founding event, Blood, vol.103, issue.5, pp.1937-1977, 2004. ,
DOI : 10.1182/blood-2003-07-2550
VHL mutation analysis in patients with isolated central nervous system haemangioblastoma, Brain, vol.130, issue.3, pp.836-878, 2007. ,
DOI : 10.1093/brain/awl362
URL : http://doi.org/10.1093/brain/awl362
Germline mutation profile of the VHL gene in von Hippel???Lindau disease and in sporadic hemangioblastoma, Human Mutation, vol.12, issue.6, pp.424-454, 1998. ,
DOI : 10.1002/(SICI)1098-1004(1998)12:6<424::AID-HUMU9>3.3.CO;2-8
Germline mutations in the Von Hippel-Lindau disease (VHL) gene in families from North America, Europe, and Japan, Human Mutation, vol.25, issue.4, pp.348-57, 1996. ,
DOI : 10.1002/(SICI)1098-1004(1996)8:4<348::AID-HUMU8>3.0.CO;2-3
Structure of an HIF-1alpha -pVHL Complex: Hydroxyproline Recognition in Signaling, Science, vol.296, issue.5574, pp.1886-1895, 2002. ,
DOI : 10.1126/science.1073440
Ectopic expression of von Hippel???Lindau tumor suppressor induces apoptosis in 786-O renal cell carcinoma cells and regresses tumor growth of 786-O cells in nude mouse, Biochemical and Biophysical Research Communications, vol.320, issue.3, pp.945-50, 2004. ,
DOI : 10.1016/j.bbrc.2004.06.042
Genome-wide Association of Hypoxia-inducible Factor (HIF)-1?? and HIF-2?? DNA Binding with Expression Profiling of Hypoxia-inducible Transcripts, Journal of Biological Chemistry, vol.284, issue.25, pp.16767-75, 2009. ,
DOI : 10.1074/jbc.M901790200
Concordant Regulation of Gene Expression by Hypoxia and 2-Oxoglutarate-dependent Dioxygenase Inhibition: THE ROLE OF HIF-1??, HIF-2??, AND OTHER PATHWAYS, Journal of Biological Chemistry, vol.281, issue.22, pp.15215-15241, 2006. ,
DOI : 10.1074/jbc.M511408200
Patterns of Gene Expression and Copy-Number Alterations in von-Hippel Lindau Disease-Associated and Sporadic Clear Cell Carcinoma of the Kidney, Cancer Research, vol.69, issue.11, pp.4674-81, 2009. ,
DOI : 10.1158/0008-5472.CAN-09-0146
The Mechanism of Ubiquitination in the Cullin-RING E3 Ligase Machinery: Conformational Control of Substrate Orientation, PLoS Computational Biology, vol.215, issue.10, p.1000527, 2009. ,
DOI : 10.1371/journal.pcbi.1000527.s008
Inhibition of HIF2?? Is Sufficient to Suppress pVHL-Defective Tumor Growth, PLoS Biology, vol.146, issue.3, p.83, 2003. ,
DOI : 10.1371/journal.pbio.0000083.g004
Common genetic variants at the 11q13.3 renal cancer susceptibility locus influence binding of HIF to an enhancer of cyclin D1 expression, Nature Genetics, vol.62, issue.4, pp.420-425, 2012. ,
DOI : 10.1101/gr.885403
Mutations, The Journal of Clinical Endocrinology & Metabolism, vol.91, issue.11, pp.4593-4601, 2006. ,
DOI : 10.1210/jc.2006-0920
URL : https://hal.archives-ouvertes.fr/hal-00652407
Gain-of-Function Mutations in Paraganglioma with Polycythemia, New England Journal of Medicine, vol.367, issue.10, pp.922-952, 2012. ,
DOI : 10.1056/NEJMoa1205119
Integrative Genomic Analyses of Sporadic Clear Cell Renal Cell Carcinoma Define Disease Subtypes and Potential New Therapeutic Targets, Cancer Research, vol.72, issue.1, pp.112-133, 2012. ,
DOI : 10.1158/0008-5472.CAN-11-1698
Multilevel Whole-Genome Analysis Reveals Candidate Biomarkers in Clear Cell Renal Cell Carcinoma, Cancer Research, vol.72, issue.20, pp.5273-84, 2012. ,
DOI : 10.1158/0008-5472.CAN-12-0656
The G-Protein-Coupled Receptor CLR Is Upregulated in an Autocrine Loop with Adrenomedullin in Clear Cell Renal Cell Carcinoma and Associated with Poor Prognosis, Clinical Cancer Research, vol.19, issue.20, pp.5740-5748, 2013. ,
DOI : 10.1158/1078-0432.CCR-13-1712
Contrasting effects on HIF-1alpha regulation by disease-causing pVHL mutations correlate with patterns of tumourigenesis in von Hippel-Lindau disease, Human Molecular Genetics, vol.10, issue.10, pp.1029-1067, 2001. ,
DOI : 10.1093/hmg/10.10.1029
VHL Type 2B Mutations Retain VBC Complex Form and Function, PLoS ONE, vol.104, issue.11, p.3801, 2008. ,
DOI : 10.1371/journal.pone.0003801.g004
URL : http://doi.org/10.1371/journal.pone.0003801
Haploinsufficiency for tumour suppressor genes: when you don't need to go all the way, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, vol.1654, issue.2, pp.105-127, 2004. ,
DOI : 10.1016/j.bbcan.2004.01.001
Loss of JAK2 regulation via a heterodimeric VHL-SOCS1 E3 ubiquitin ligase underlies Chuvash polycythemia, Nature Medicine, vol.90, issue.7, pp.845-53, 2011. ,
DOI : 10.1002/ajh.21381
Somatic inactivation of the VHL gene in Von Hippel-Lindau disease tumors, Am J Hum Genet, vol.60, pp.765-71, 1997. ,
Neuronal apoptosis linked to EglN3 prolyl hydroxylase and familial pheochromocytoma genes: Developmental culling and cancer, Cancer Cell, vol.8, issue.2, pp.155-67, 2005. ,
DOI : 10.1016/j.ccr.2005.06.015
URL : http://doi.org/10.1016/j.ccr.2005.06.015
Von Hippel-Lindau (VHL) disease with pheochromocytoma in the Black Forest region of Germany: evidence for a founder effect, Human Genetics, vol.95, issue.5, pp.551-557, 1995. ,
DOI : 10.1007/BF00223868
Genotype-phenotype correlation in von Hippel-Lindau families with renal lesions, Human Mutation, vol.8, issue.1, pp.215-239, 2004. ,
DOI : 10.1002/humu.20082
Congenital polycythemia with homozygous and heterozygous mutations of von Hippel-Lindau gene: five new Caucasian patients, Haematologica, vol.90, pp.128-137, 2005. ,
von Hippel-Lindau Disease and Erythrocytosis, Journal of Clinical Oncology, vol.30, issue.13, pp.137-146, 2012. ,
DOI : 10.1200/JCO.2011.38.6797
T124A/L188V) associated with congenital polycythaemia, British Journal of Haematology, vol.98, issue.6, pp.851-854, 2013. ,
DOI : 10.1111/bjh.12431
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3759558
Mutations of von Hippel-Lindau Tumor-Suppressor Gene and Congenital Polycythemia, The American Journal of Human Genetics, vol.73, issue.2, pp.412-421, 2003. ,
DOI : 10.1086/377108
Mutations in the VHL gene in sporadic apparently congenital polycythemia, Blood, vol.101, issue.4, pp.1591-1596, 2003. ,
DOI : 10.1182/blood-2002-06-1843
Isolated familial pheochromocytoma as a variant of von Hippel- Lindau disease, J Clin Endocrinol Metab, vol.81, pp.1035-1042, 1996. ,
The role of PHD2 mutations in the pathogenesis of erythrocytosis, Hypoxia, vol.2, pp.71-90, 2014. ,
DOI : 10.2147/HP.S54455
Mutation and Congenital Erythrocytosis with Paraganglioma, New England Journal of Medicine, vol.359, issue.25, pp.2685-92, 2008. ,
DOI : 10.1056/NEJMoa0806277
A novel EPAS1/HIF2A germline mutation in a congenital polycythemia with paraganglioma, Journal of Molecular Medicine, vol.359, issue.4, pp.507-519, 2013. ,
DOI : 10.1007/s00109-012-0967-z
Distinct deregulation of the hypoxia inducible factor by PHD2 mutants identified in germline DNA of patients with polycythemia, Haematologica, vol.97, issue.1, pp.9-14, 2012. ,
DOI : 10.3324/haematol.2011.044644
URL : https://hal.archives-ouvertes.fr/inserm-01401555
PHDs overactivation during chronic hypoxia "desensitizes" HIF?? and protects cells from necrosis, Proceedings of the National Academy of Sciences, vol.105, issue.12, pp.4745-50, 2008. ,
DOI : 10.1073/pnas.0705680105
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2290777